Skip to main content
. 2018 Oct 29;4(4):353–363. doi: 10.3233/BLC-180179

Table 3.

Post-test probabilities of bladder cancer in asymptomatic microscopic hematuria (pre-test cancer probability: 2.1% [34])

Biomarker Positive LR Negative LR Post-test probability with positive test (%) Post-test probability with negative test (%)
AssureMDx 6.6 0.07 12.40 0.15
BTA 2.1 0.5 4.31 1.06
CxBladder 5.5 0.21 10.55 0.45
NMP22 (qualitative) 4.6 0.36 6.61 0.62
NMP22 (quantitative) 3.3 0.29 8.98 0.77
uCyt+ 6.2 0.2 11.74 0.43
UroVysion 3.3 0.4 6.61 0.85